Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06808230 · ClinicalTrials.gov registry record · NA

Cocoa Extract for Migraine Trial

A NA study of Migraine, sponsored by Brigham and Women's Hospital.

Recruiting
Registry status
NA
Development phase
114
Enrollment target
1
Study location

NCT06808230 is a NA study of Migraine that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 114 participants, below the 357-participant average among 102 other Migraine trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06808230, a NA study of Migraine, is actively recruiting participants, sponsored by Brigham and Women's Hospital.

RECRUITING
Registry status
NA
Development phase
114 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to assess the feasibility of recruitment and adherence to a high-dose cocoa extract supplement in individuals diagnosed with episodic migraine. The main questions it aims to answer are: * Will we be able to enroll 114 participants during the recruitment period? * Will participants take study pills daily during the pill-taking period? Researchers will compare two doses of cocoa extract to placebo to determine the acceptability of higher doses of cocoa extract supplementation in this patient population. Participants will be asked to: * Provide two urine samples * Complete daily questionnaires * Take four study pills a day for 12 weeks

Conditions Studied

Migraine

Interventions

  • DIETARY_SUPPLEMENT Cocoa extract
  • DIETARY_SUPPLEMENT Cocoa extract placebo

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 114 participants
Start Date 2025-06-23
Est. Completion 2026-12-01
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06808230

The ClinicalTrials.gov registry entry for NCT06808230 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 357-participant average among 102 other Migraine trials with a reported enrollment target (68% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Migraine appearing as the primary indexed condition, and to 2 interventions - of which Cocoa extract is the first listed.

NCT06808230 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06808230 about?

NCT06808230 is a clinical study titled "Cocoa Extract for Migraine Trial". The goal of this clinical trial is to assess the feasibility of recruitment and adherence to a high-dose cocoa extract supplement in individuals diagnosed with episodic migraine. The main questions it aims to answer are: * Will we be able to enroll 114 participants during the recruitment period? * ...

What is the current status of trial NCT06808230?

This trial is currently recruiting. It is a NA study. The enrollment target is 114 participants. The study started on 2025-06-23. Estimated completion is 2026-12-01.

What conditions does trial NCT06808230 study?

This clinical trial studies the following conditions: Migraine.

What interventions are being tested in trial NCT06808230?

The interventions under investigation include: Cocoa extract (DIETARY_SUPPLEMENT), Cocoa extract placebo (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06808230?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06808230 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Migraine

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Migraine

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.